Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease.
about
New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyondPopulation stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.Low glucose utilization and neurodegenerative changes caused by sodium fluoride exposure in rat's developmental brain.LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset.Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1αThe V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients.Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationPGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.Hepatitis C virus utilizes VLDLR as a novel entry pathway.Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes.Targeting Huntington's disease through histone deacetylases.Genetic modifiers of Huntington's disease.Modern Genome Editing Technologies in Huntington's Disease Research.The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.Knock out of neuronal nitric oxide synthase exacerbates intestinal ischemia/reperfusion injury in mice.Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice.Genetic modifiers in Huntington's disease: fiction or fact?mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease.Towards an Understanding of Energy Impairment in Huntington's Disease Brain.PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity.Malnutrition in Stroke Patients: Risk Factors, Assessment, and Management.Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
P2860
Q26996576-ED564855-EA44-4852-90AD-B51AEEC33242Q30424048-012C5C52-9A72-4F65-92B4-42C21A329DE3Q30663721-9472A661-64AF-434D-A40D-FD514B6F165AQ30831806-632BD870-FCAB-4381-BC69-E9BF4BE01355Q34275231-CA3BC4F8-43A2-413D-8C27-C173028BE0EBQ34312581-80F36394-6C98-402F-97C5-2A99B0D61289Q34391101-C904AF93-770B-4F7A-9600-5362B5B45999Q34873673-1ADAD972-4732-48C9-AF86-3DDFC542ED9AQ34944325-A24CAD01-F445-4D24-9C2E-62F3E47C849EQ35052819-C1CEBBCE-D68F-4B13-A1CC-0B64C0480E46Q35079574-5241CF48-9668-4050-8FD4-1A0A3FB89A0DQ35684210-35E9A723-70F7-4217-9F3F-411AABAE38A8Q36459392-24D00212-A4B4-4025-8112-BCE4433FA285Q37013924-71A8F781-B730-4361-ADD0-2175991569F0Q38019159-E7470510-03B3-4851-B1F7-E65017859257Q38243002-171F9950-70F7-4F98-9031-281CBAB482CAQ39106522-6ED27F99-BE64-46FD-AB4C-AA0274E5D357Q39427395-CCE8C4D6-4CDA-4F8D-A4EA-C40DCCABFD8EQ41721818-CFF847EA-DB78-4CB6-B4D2-508BFC468912Q42507828-20DE4CFA-1118-4FCC-B185-413B6AD90E90Q43878437-07779BBE-B54F-4367-8D7B-7EF5C42AA413Q44453146-6064A6C3-6E76-47B0-B8D0-612EA9894195Q45302304-25001DB9-1C22-40B4-803C-20F738644EB5Q47442924-54EC2353-B3D6-40EC-9AD0-8DEA69B4723DQ47892728-6EEFB12F-8766-48D0-8BCD-B231F567BCF1Q48255266-D1A860C1-6794-4FCE-9B20-59D047CBD708Q54965657-B72BE082-9488-46F8-BC9F-6DB3B8A5DA64Q58584663-6A2BB767-15B7-4230-B970-EDF05BFF265D
P2860
Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Localization of sequence varia ...... effect in Huntington disease.
@ast
Localization of sequence varia ...... effect in Huntington disease.
@en
Localization of sequence varia ...... effect in Huntington disease.
@nl
type
label
Localization of sequence varia ...... effect in Huntington disease.
@ast
Localization of sequence varia ...... effect in Huntington disease.
@en
Localization of sequence varia ...... effect in Huntington disease.
@nl
prefLabel
Localization of sequence varia ...... effect in Huntington disease.
@ast
Localization of sequence varia ...... effect in Huntington disease.
@en
Localization of sequence varia ...... effect in Huntington disease.
@nl
P2093
P2860
P50
P356
P1476
Localization of sequence varia ...... g effect in Huntington disease
@en
P2093
Carolin Deyle
Esteban Portal
Hong Van B Che
P2860
P2888
P356
10.1186/1750-1326-6-1
P577
2011-01-06T00:00:00Z
P5875
P6179
1006884665